Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 71
Filter
1.
Eur Rev Med Pharmacol Sci ; 26(21): 7742-7755, 2022 11.
Article in English | MEDLINE | ID: mdl-36394722

ABSTRACT

OBJECTIVE: This study aimed to evaluate the effect of resistance exercise on peripheral inflammatory biomarkers in healthy adults. MATERIALS AND METHODS: Four databases, including PubMed, Web of Science, Cochrane Library, and SPORTDiscus, were searched from inception until April 1st, 2022. A meta-analysis was conducted using a random-effects model, followed by sensitivity analysis, subgroup analysis, meta-regression analysis, and publication bias analysis. RESULTS: 15 randomized controlled trials were included in the meta-analysis. The pooled results showed that resistance exercise significantly decreased TNF-α levels (SMD = -0.81, 95% CI: -1.42 to -0.20, p = 0.009) but did not affect IL-6 and CRP levels. Individuals with BMI 18.5-24.9 exhibited significantly decreased IL-6 levels, while moderate strength resistance exercise could significantly decrease TNF-α levels. Finally, age might be a confounding factor influencing the effect of resistance exercise on IL-6. CONCLUSIONS: Resistance exercise could reduce TNF-α levels in healthy adults, and resistance exercise with moderate intensity could reduce TNF-α levels more effectively.


Subject(s)
Resistance Training , Tumor Necrosis Factor-alpha , Humans , Interleukin-6 , Randomized Controlled Trials as Topic , Biomarkers
2.
Zhonghua Zhong Liu Za Zhi ; 44(3): 219-227, 2022 Mar 23.
Article in Chinese | MEDLINE | ID: mdl-35316871

ABSTRACT

Non-small cell lung cancer (NSCLC) is one of the most severe malignant tumors worldwide. Lobectomy and systematic nodal dissection remain the standard treatment for stageⅠNSCLC. Stereotactic body radiotherapy (SBRT) has become the standard treatment for medically inoperable patients. Though the prognosis of stage Ⅰ NSCLC patients is generally good, there are still about 20% of patients with local recurrence and distant metastasis. There is significant heterogeneity in the prognosis and failure phenotype of patients, which cannot be precisely distinguished by the pathological TNM classification system. Identification of the risk factors for the prognosis of patients with stage Ⅰ NSCLC is a key step to realize the treatment from experience to precision. Screening the high-risk patients will facilitate to individually develop the adjuvant therapy strategy after surgery or SBRT and improve the overall curative effect. There are many factors that are significantly related to the prognosis of stage Ⅰ NSCLC including individual factors such as gender, age, and systemic inflammatory biomarkers; treatment-related factors such as the extent of surgical resection of the primary tumor and lymph nodes, the choice of different radiation rays, and different dose fractionation; and tumor-related factors such as imaging information, pathology information; and molecular biology information. This review will analyze the treatment failure phenotype and prognostic factors of stageⅠ NSCLC in various perspectives such as individual-, tumor- and treatment-related factors.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Non-Small-Cell Lung/radiotherapy , Carcinoma, Non-Small-Cell Lung/surgery , Humans , Lung Neoplasms/pathology , Phenotype , Prognosis , Treatment Failure
3.
Zhonghua Gan Zang Bing Za Zhi ; 29(7): 659-665, 2021 Jul 20.
Article in Chinese | MEDLINE | ID: mdl-34371536

ABSTRACT

Objective: To investigate the effect of programmed death receptor (PD)-1 antibody therapy in patients with hepatitis B-associated liver cancer. Methods: Data of 29 chronically infected HBV patients with liver cancer who received PD-1 antibody combined with tyrosine kinase inhibitor in the Department of Infectious Diseases of the Fifth Medical Center of PLA General Hospital from March 2020 to January 2021 were selected. At the same time, all of the above-mentioned hepatitis B virus (HBV) patients were treated with nucleos(t)ide analogues. Patients clinical diagnostic data, laboratory test results, tumor response and the incidence of adverse reactions were collected retrospectively to understand the overall safety, therapeutic anti-tumor effect, HBV changes condition and the correlation between HBV changes and anti-tumor PD-1 antibody efficacy, high viral load treatment condition, and HBV reactivation safety issues. Statistical analysis was performed by non-parametric rank sum test. Results: Therapeutic anti-tumor effect and safety profile were good in patients. The complete remission rate was reached 27.6%. Adverse reactions were mostly mild, and the incidence of serious adverse reactions was low. After 12 weeks of follow-up, HBV DNA and hepatitis B surface antigen (HBsAg) was quantitatively decreased (P < 0.05). HBV DNA and HBsAg were decreased more significantly in patients with progressive disease (PD), stable disease (SD) and partial response (PR) (P < 0.05). Five patients with HBV DNA ≥ 10(4) IU/ml had responded well to the tumor treatment without serious adverse reactions. One patient had a slight increase in HBV DNA and alanine aminotransferase, while there was no HBV reactivation and correlated liver damage. Conclusion: Patients with HBV-associated liver cancer who received combined therapy have good anti-tumor efficacy and safety profile. PD-1 treatment has a certain effect on HBV. Compared with non-responders, patients with tumor response have better antiviral treatment efficacy. The safety of treatment in patients with high viral load is manageable, and there are no safety issues related to HBV reactivation.


Subject(s)
Hepatitis B , Liver Neoplasms , Antiviral Agents/therapeutic use , DNA, Viral , Hepatitis B/complications , Hepatitis B/drug therapy , Hepatitis B Surface Antigens , Hepatitis B virus/genetics , Humans , Liver Neoplasms/drug therapy , Receptors, Death Domain , Retrospective Studies , Virus Activation
4.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi ; 33(2): 110-119, 2021 Mar 25.
Article in Chinese | MEDLINE | ID: mdl-34008356

ABSTRACT

With the rapid development of global tourism, traveling gradually becomes an important part of daily lives, and travelers'health is paid more and more attention. Traveler's diarrhea (TD) is one of the most common diseases among international or trans-regional travelers, which causes great disease and economic burdens. Currently, there is still a lack of systematic studies on the correlation between parasites and TD. The review mainly summarizes intestinal protozoa and helminth infections among patients with TD, so as to provide insights into the development of the control measures for parasitic diseases associated with TD and the prevention of risk factors before the journey to and during the journey of the areas endemic for parasitic diseases.


Subject(s)
Diarrhea , Parasitic Diseases , Humans , Parasitic Diseases/epidemiology , Risk Factors , Travel
5.
Clin Exp Dermatol ; 46(7): 1293-1298, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33763912

ABSTRACT

The effects of cigarette smoking on the risk of herpes zoster (HZ) infection remain unclear. This study aimed to examine the association between cigarette smoking and HZ. Participants were collected from four rounds (2001, 2005, 2009 and 2013) of the Taiwan National Health Interview Survey. Incident cases of HZ were identified from the Taiwanese National Health Insurance database. Of the 57 641 participants, 3346 developed HZ during the observation period. After controlling for confounders, current smokers had a lower risk of incident HZ than never-smokers (adjusted hazard ratio 0.69; 95% CI 0.62-0.77). There was a trend toward a decreased risk of HZ with increasing numbers of cigarettes per day, years of smoking and cumulative pack-years of smoking among current smokers (Ptrend < 0.001). Former smoking was not associated with risk of HZ. In conclusion, current smoking was significantly associated with a decreased risk of developing HZ.


Subject(s)
Cigarette Smoking , Herpes Zoster/epidemiology , Adult , Cohort Studies , Female , Health Surveys , Herpes Zoster/prevention & control , Humans , Male , Middle Aged , Risk Factors , Taiwan/epidemiology
7.
Article in Chinese | MEDLINE | ID: mdl-32185929

ABSTRACT

OBJECTIVE: To characterize the trehalase gene in Thelazia callipaeda through screening the annotated data of the T. callipaeda genome, and to investigate the biological characteristics of the trehalase gene-coding protein. METHODS: The trehalase gene was screened from the T. callipaeda genome and subjected to validation by using a PCR assay. The structural features of the coding protein were analyzed with bioinformatics tools, including hydrophobicity, transmembrane region, signal peptides, conserved domains, as well as the secondary and tertiary structures and the antigen epitope. Homology analysis of the amino acid sequences was performed, and the phylogenetic tree was built by the MEGA X software. In addition, the protein-protein interaction network was deduced from the STRING database. RESULTS: The sequence of the trehalase gene with the complete CDS region was obtained from T. callipaeda genome, which had a length of 1 638 bp and encoded 545 amino acids. The encoded protein was predicted to have a molecular weight of 63 478.48 ku and be a secretory protein. The 5' domain of the encoded protein contained a signal peptide without transmembrane regions, and was predicted to contain 7 antigen epitopes. Based on the protein-protein interaction network of nematodes in the STRING database, the protein-protein interaction network of the trehalase gene of T. callipaeda was deduced, and 27 interactions covering 10 genes were identified. CONCLUSIONS: A trehalase gene is successfully identified in T. callipaeda genome and its coding protein receives a bioinformatics analysis, which provides insights into the research on the biological functions of the protein and the screening of vaccine candidates for thelaziasis callipaeda.


Subject(s)
Computational Biology , Thelazioidea , Trehalase , Animals , Phylogeny , Spirurida Infections/parasitology , Thelazioidea/classification , Thelazioidea/enzymology , Thelazioidea/genetics , Trehalase/genetics , Trehalase/metabolism
8.
Zhonghua Wai Ke Za Zhi ; 57(6): 418-421, 2019 Jun 01.
Article in Chinese | MEDLINE | ID: mdl-31142065

ABSTRACT

Objective: To investigate the short-term efficacy and adverse events of chemotherapy combined with androgen-deprivation therapy in high-volume metastatic hormone sensitive prostate cancer. Methods: From March 2015 to August 2017, 55 patients with high-volume metastatic hormone sensitive prostate cancer were enrolled at Department of Urology, Fudan University Shanghai Cancer Center receiving chemotherapy combined with androgen-deprivation therapy. The age was 65(8) years (M(Q(R))) (range: 46 to 79 years). Patients were enrolled in the study for continuous androgen-deprivation therapy (medical or surgical castration), combined with docetaxel 75 mg/m(2) intravenous injection on the first day, repeated every 21 days (6 cycles). Endpoints included overall survival, progression-free survival of prostate cancer, prostate specific antigen (PSA) response rate, and adverse events. Results: The follow-up time was 21.2(11.7) months. The PSA value before chemotherapy was 144.9(415.3) µg/L. The days in patients undergoing androgen deprivation therapy before chemotherapy was 14(23) days. Four patients (7.3%) presented 0 in Eastern Cooperative Oncology Group scoring system and 51 patients(92.7%) presented 1. Thirty-nine patients (70.9%) completed more than 6 cycles of combined chemotherapy, 17 patients (30.9%) showed PSA<0.2 µg/L at 6 months after treatment, and 14 patients (25.5%) showed PSA<0.2 µg/L at 12 months after treatment. Twenty-eight patients (50.9%) had grade 3 to 4 neutropenia and 1 patient (1.8%) developed infectious neutropenia and died. Nausea and vomit occurred in 16 patients (29.1%). Twelve patients (21.8%) underwent dose adjustment due to adverse events in blood system. Conclusions: The short-term effect was confirmed in high-volume metastatic hormone sensitive prostate cancer using chemotherapy combined androgen-deprivation therapy, and the long-term effect remains to be seen. Myelosuppression during chemotherapy requires close attention, and taking timely examination is recommended.


Subject(s)
Antineoplastic Agents/therapeutic use , Docetaxel/therapeutic use , Prostatic Neoplasms/drug therapy , Aged , Androgen Antagonists/adverse effects , Androgen Antagonists/therapeutic use , Antineoplastic Agents/adverse effects , Biomarkers, Tumor/blood , Docetaxel/adverse effects , Humans , Male , Middle Aged , Orchiectomy , Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Prostatic Neoplasms/surgery , Treatment Outcome
9.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi ; 31(6): 622-627, 2019 Nov 12.
Article in Chinese | MEDLINE | ID: mdl-32064806

ABSTRACT

OBJECTIVE: To investigate the dynamics changes of the myeloid-derived suppressor cells (MDSCs) and regulatory T (Treg) cells in mice infected with Echinococcus granulosus and explore the possible biological significance. METHODS: Thirty female BALB/c mice of 6 weeks old were randomly divided into the infection and control groups, of 15 mice in each group. Mice in the infection group were intraperitoneally injected with 2 000 E. granulosus protoscoleces, while those in the control group were injected with the same volume of physiological saline. Mouse liver white blood cells were harvested 3 (early stage), 6 (medium stage) and 12 months (late stage) post-infection, and the proportions of MDSCs, their subpopulations (M-MDSCs and PMN-MDSCs) and Treg cells were assessed by flow cytometry. RESULTS: The proportions of MDSCs were (1.61 ± 0.36)%, (5.68 ± 0.69)% and (16.18 ± 0.69)% in mouse liver white blood cells in the infection group 3, 6 and 12 months post-infection with E. granulosus, and (2.19 ± 0.42)%, (0.99 ± 0.07) % and (4.18 ± 0.84)% in the control group, and there were significant differences in the proportion of the MDSCs in mouse liver white blood cells between the infection and control groups 6 and 12 months post-infection (P < 0.01). The proportions of M-MDSCs were (0.69 ± 0.27)%, (5.30 ± 0.72)% and (10.75 ± 0.29)% in mouse liver white blood cells in the infection group 3, 6 and 12 months post-infection, and (0.42 ± 0.24)%, (0.69 ± 0.02)% and (2.12 ± 0.13)% in the control group, and there were significant differences in the proportion of the M-MDSCs in the mouse liver white blood cells between the infection and control groups 6 and 12 months post-infection (P < 0.01). The proportions of PMN-MDSCs were (0.93 ± 0.23)%, (0.32 ± 0.02)% and (5.14 ± 1.03)% in mouse liver white blood cells in the infection group 3, 6 and 12 months post-infection, and (1.77 ± 0.26)%, (0.28 ± 0.05)% and (1.99 ± 0.90)% in the control group, and there were significant differences in the proportion of PMN-MDSCs in mouse liver white blood cells between the infection and control groups 3 and 12 months post-infection (P < 0.05). The proportions of Treg cells were (3.35 ± 0.14)%, (6.24 ± 0.38)% and (3.41 ± 0.07)% in mouse liver white blood cells in the infection group 3, 6 and 12 months post-infection, and (3.48 ± 0.46)%, (3.65 ± 0.45)% and (3.12 ± 0.12)% in the control group, and there were significant differences in the proportion of Treg cells in mouse liver white blood cells between the infection and control groups 6 and 12 months post-infection (P < 0.01). CONCLUSIONS: The percentages of both MDSCs and Treg cells increase in mouse liver white blood cells 6 and 12 months post-infection with E. granulosus, and a more remarkable increase is seen in the percentage of MDSCs, which is mainly found in M-MDSCs. These findings suggest that M-MDSCs may play a major immunosuppressive role in the medium and late stages of E. granulosus infection in mice.


Subject(s)
Echinococcosis , Echinococcus granulosus , Liver , Myeloid-Derived Suppressor Cells , T-Lymphocytes, Regulatory , Animals , Echinococcosis/immunology , Echinococcus granulosus/immunology , Female , Liver/immunology , Liver/parasitology , Mice , Mice, Inbred BALB C , Myeloid-Derived Suppressor Cells/immunology , Random Allocation , T-Lymphocytes, Regulatory/immunology
10.
Vet J ; 234: 24-26, 2018 04.
Article in English | MEDLINE | ID: mdl-29680388

ABSTRACT

Thirty clinical isolates of H. parasuis from pig farms in eastern China were screened for antimicrobial susceptibility. A novel plasmid, designated pHPSGC, was extracted from one isolate with evidence of resistance (elevated minimum inhibitory concentration) to florfenicol. DNA sequencing demonstrated that pHPSGC (5297 base pairs) contains three open reading frames (ORFs), corresponding to the genes rep, floR and lysR. The rep gene of pHPSGC shared 99% sequence identity with the rep gene of pHPS1019. In addition, the region containing floR and lysR in pHPSGC shared 99% similarity with the corresponding region of pCCK381. pHPSGC may be derived from a recombination event between pHPS1019 and pCCK381. A florfenicol resistance gene in H. parasuis may have been transferred via recombination between different plasmids.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Haemophilus parasuis/drug effects , Plasmids/genetics , Thiamphenicol/analogs & derivatives , Animals , China , DNA, Bacterial/genetics , Genes, Bacterial , Haemophilus parasuis/genetics , Molecular Sequence Data , Thiamphenicol/pharmacology
11.
Zhonghua Zhong Liu Za Zhi ; 39(9): 695-700, 2017 Sep 23.
Article in Chinese | MEDLINE | ID: mdl-28926900

ABSTRACT

Objective: To investigate the safety and efficacy of radiofrequency ablation (RFA) with percutaneous iohexol-ethanol injection (PIEI), compared with RFA plus transcatheter arterial chemoembolization (TACE) for patients with primary liver cancer(PLC)in high-risk locations. Methods: From January 2012 to December 2014, 54 patients with PLC in high-risk locations were enrolled. They were divided into Group A (RFA combined with PIEI) and Group B (RFA plus TACE). The efficacy and adverse events were assessed. Results: 54 patients had 74 lesions in high-risk locations. There were 26 cases with 40 lesions in Group A, and 28 cases with 34 lesions in Group B. The complete ablation rate of Group A was significantly higher than that of Group B (92.5% vs 70.6%, P=0.014). The two-year local tumor progressionrateand two-year overall survival rate were similar between these two groups (Group A 20.0% vs Group B 38.2%, P=0.083; 90.3% vs 84.3%, P=0.523). Furthermore, the surgery-related severe adverse events of Group A (7.1%, one case of liver abscess and one case ofhematobilia) were more common than that of Group B (0%, P=0.491). No significant differences were found in common adverse events including fever, pain, elevation of aminotransferase and bilirubin. Conclusions: Compared with RFA plus TACE, RFA plus PIEI resulted inbetter complete ablation rate in patients with primary liver cancer in high risk locations. Prospective, randomized, controlled trials are warranted for further evaluation.


Subject(s)
Carcinoma, Hepatocellular/therapy , Catheter Ablation/methods , Chemoembolization, Therapeutic/methods , Contrast Media/administration & dosage , Ethanol/administration & dosage , Iohexol/administration & dosage , Liver Neoplasms/therapy , Radiofrequency Ablation/methods , Carcinoma, Hepatocellular/pathology , Catheter Ablation/adverse effects , Chemoembolization, Therapeutic/adverse effects , Combined Modality Therapy/adverse effects , Combined Modality Therapy/methods , Humans , Liver Abscess/etiology , Liver Neoplasms/pathology , Prospective Studies , Radiofrequency Ablation/adverse effects , Survival Rate , Treatment Outcome
13.
Neurochem Res ; 41(5): 958-64, 2016 May.
Article in English | MEDLINE | ID: mdl-26471165

ABSTRACT

Reactive oxygen species (ROS) play a critical role in the pathogenesis of neuropathic pain, but few studies have examined the role of oxidative stress in the mirror-image neuropathic pain (MINP). The present study was to investigate the role of ROS in MINP caused by chronic compression of the dorsal root ganglion (DRG) (CCD) in a rat model. SD rats were randomly divided into sham group and CCD group. CCD was conducted to induce MINP. CCD rats were intraperitoneally injected with α-Phenyl-N-tert-butyl-nitrone (PBN) at 7 days after surgery. Paw withdrawal mechanical threshold (PWMT) was measured at -1, 1, 3, 5 and 7 days after surgery in sham group and CCD group, and at 8 time points after PBN injection. Rats were sacrificed at 3 and 7 days after surgery in sham group and CCD group and at 0.5 and 2 h after PBN injection, and the superoxide dismutase (SOD) and catalase activities, as well as hydrogen peroxide (H2O2) and malonaldehyde (MDA) contents were determined in the contralateral DRGs. Results showed bilateral PWMT reduced significantly in sham group and CCD group, but it returned to nearly normal level in sham group. MDA content, H2O2 content and SOD activity increased significantly, while catalase activity remained unchanged in CCD rats. PBN at 100 mg/kg significantly attenuated bilateral mechanical hyperalgesia accompanied by the improvement of oxidative stress in the contralateral DRGs. Our results demonstrate that ROS produced in the contralateral DRG are involved in the pathogenesis of CCD induced MINP, and ROS scavenger may be a promising drug for the therapy of MINP.


Subject(s)
Ganglia, Spinal/physiopathology , Neuralgia/physiopathology , Oxidative Stress , Spinal Cord Compression/physiopathology , Animals , Chronic Disease , Cyclic N-Oxides/pharmacology , Cyclic N-Oxides/therapeutic use , Free Radical Scavengers/pharmacology , Free Radical Scavengers/therapeutic use , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Male , Neuralgia/drug therapy , Neuralgia/metabolism , Oxidation-Reduction , Random Allocation , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Spinal Cord Compression/drug therapy , Spinal Cord Compression/metabolism
14.
Neuroscience ; 293: 12-22, 2015 May 07.
Article in English | MEDLINE | ID: mdl-25732137

ABSTRACT

Mood disorders are a severe health burden but molecular mechanisms underlying mood dysfunction remain poorly understood. Here, we show that wild-type p53-induced phosphatase 1 (Wip1) negatively responds to the stress-induced negative mood-related behaviors. Specifically, we show that Wip1 protein but not its mRNA level was downregulated in the hippocampus but not in the neocortex after 4 weeks of chronic unpredictable mild stress (CUMS) in mice. Moreover, the CUMS-responsive WIP1 downregulation in the hippocampus was restored by chronic treatment of fluoxetine (i.p. 20 mg/kg) along with the CUMS procedure. In addition, Wip1 knockout mice displayed decreased exploratory behaviors as well as increased anxiety-like and depression-like behaviors in mice without impaired motor activities under the non-CUMS condition. Furthermore, the Wip1 deficiency-responsive anxiety-like but not depression-like behaviors were further elevated in mice under CUMS. Although limitations like male-alone sampling and multiply behavioral testing exist, the present study suggests a potential protective function of Wip1 in mood stabilization.


Subject(s)
Anxiety/metabolism , Depression/metabolism , Hippocampus/metabolism , Phosphoprotein Phosphatases/metabolism , Animals , Antidepressive Agents, Second-Generation/pharmacology , Anxiety/physiopathology , Depression/physiopathology , Exploratory Behavior/physiology , Fluoxetine/pharmacology , Hippocampus/drug effects , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Phosphoprotein Phosphatases/genetics , Protein Phosphatase 2C , RNA, Messenger/metabolism , Stress, Psychological/metabolism , Stress, Psychological/physiopathology
15.
Opt Lett ; 39(21): 6328-30, 2014 Nov 01.
Article in English | MEDLINE | ID: mdl-25361346

ABSTRACT

Spectroscopic characterization of a Ho:LuVO4 crystal grown by the Czochralski method has been performed, including the absorption and emission spectra. We demonstrate a 2 µm room temperature Ho:LuVO4 laser, resonantly pumped by a 1.94 µm Tm:YAP laser. By use of an output coupler with T=10% transmission, the Ho:LuVO4 laser generated continuous-wave output power of 2.5 W at 2074.18 nm, with a beam quality factor of Mx2=My2=1.3, for a total incident pump power of 19.4 W. The slope efficiency with respect to the pump power was 17.6%, and the optical-to-optical efficiency was 12.9%. Moreover, we obtained a Ho:LuVO4 laser that operated at 2073.77 and 2055.27 nm, by using different output couplers with transmissions of T=15 and 30%.

16.
Prostate Cancer Prostatic Dis ; 17(4): 315-9, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25224557

ABSTRACT

BACKGROUND: Controversial data on the association of single-nucleotide polymorphisms (SNPs, rs3787016G>A and rs10773338G>A) in long non-coding RNA (lncRNA) with prostate cancer risk were emerged. Considering possible genetic differences among populations, we conducted the present study to clarify these discrepancies and re-validate these results in an eastern Chinese population and thus provide clues for new therapeutic targets of prostate cancer. METHODS: Genotypes of these two SNPs from 1015 ethnic Han Chinese patients with prostate cancer and 1032 cancer-free controls were determined by Taqman assays. Logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for risk associations. RESULTS: The association of rs3787016 A variant genotypes with a significantly higher prostate cancer risk were found (adjusted OR = 1.418, 95% CI = 1.090-1.844 for AA vs GG). Stratification analysis indicated that the risk of rs3787016 variant AG/AA genotypes was more evident in younger subjects, ever smoking, patients with Gleason score ⩾ 7(4+3) and highly aggressive status. All these risks were not present for rs10773338G>A. CONCLUSIONS: These findings suggested that lncRNA SNPs may contribute to prostate cancer risk in an eastern Chinese population. Larger and well-designed studies with different ethnic populations are warranted to validate our findings.


Subject(s)
Asian People/genetics , Genetic Predisposition to Disease/genetics , Polymorphism, Single Nucleotide/genetics , Prostatic Neoplasms/genetics , RNA, Long Noncoding/genetics , Adult , Aged , Aged, 80 and over , Genotype , Humans , Male , Middle Aged , Odds Ratio , Risk Factors
17.
Parasite Immunol ; 36(12): 647-57, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25099746

ABSTRACT

Our and others' previous studies have shown that Schistosoma japonicum (SJ) infection can inhibit allergic reactions. We recently reported that DCs played an important role in SJ infection-mediated inhibition of allergy, which was associated with enhanced IL-10 and T regulatory cell responses. Here, we further compared the role of CD8α(+) DC and CD8α(-) DC subsets for the inhibitory effect. We sorted CD8α(+) DC (SJCD8α(+) DC) and CD8α(-) DC (SJCD8α(-) DC) from SJ-infected mice and tested their ability to modulate allergic responses in vivo. The data showed that the adoptive transfer of SJCD8α(-) DC was much more efficient than SJCD8α(+) DC for the suppression of allergic airway eosinophilia, mucus overproduction, antigen-specific IgE responses, and Th2 cytokines (IL-4 and IL-5). More importantly, we found that the transfer of SJCD8α(-) DC, but not SJCD8α(+) DC, significantly increased IL-10 and TGF-ß production following OVA exposure. As control, the transfer of DC subsets from naïve mice had no significant effect on allergic inflammation. In addition, SJCD8α-DC expressed significantly higher IL-10 but lower IL-12, CD80 and CD86 than SJCD8α(+) DC, fitting a tolerogenic phenotype. The results suggest that CD8α(-) DC is the predominant DC subset which is involved in the parasitic infection-mediated inhibition of allergic inflammation and possibly through enhancing immunomodulatory cytokine (IL-10 and TGF-ß) production.


Subject(s)
Dendritic Cells/immunology , Hypersensitivity/immunology , Schistosomiasis japonica/immunology , Adoptive Transfer , Animals , Antigens, Helminth/immunology , CD11b Antigen , Dendritic Cells/cytology , Female , Hypersensitivity/prevention & control , Interleukin-10/immunology , Mice , Mice, Inbred BALB C , Ovalbumin , Pneumonia/chemically induced , Pneumonia/immunology , T-Lymphocytes, Helper-Inducer/immunology , Transforming Growth Factor beta/immunology
18.
Scand J Immunol ; 76(5): 491-6, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22862677

ABSTRACT

Killer cell immunoglobulin-like receptor (KIR) and human leucocyte antigen (HLA) play crucial role in maintaining immune homoeostasis and controlling immune responses. To investigate the influence of KIR and HLA-C ligands on the risk of pulmonary tuberculosis (PTB), we studied 200 patients who were confirmed to have PTB and 200 healthy controls on the different frequencies of KIR and HLA-C ligands. Genotyping of these genes was conducted by sequence-specific primer polymerase chain reaction (SSP-PCR) method. Gene frequencies were compared between PTB group and the control group by χ(2) test, and P < 0.05 was regarded as statistically significant. As a result, the frequency of KIR genotype A/B was increased in PTB than controls but A/A was decreased. Moreover, striking differences were observed in the frequencies of HLA-Cw*08 between the two groups. Besides, the frequencies of '2DL2/3 with C1' in PTB were increased compared with control group. In addition, individuals with no KIR2DS3 and no Cw*08 were higher in controls than in PTB. KIR2DS1 was increased in PTB when HLA-C group 2 alleles were missing. In conclusion, KIR and HLA-C gene polymorphisms were related to susceptibility to PTB.


Subject(s)
HLA-C Antigens/genetics , Receptors, KIR/genetics , Tuberculosis, Pulmonary/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Female , Genetic Predisposition to Disease , Genotype , HLA-C Antigens/physiology , Haplotypes , Humans , Male , Middle Aged , Receptors, KIR/physiology , Tuberculosis, Pulmonary/etiology , Tuberculosis, Pulmonary/immunology
19.
Genet Mol Res ; 11(2): 1370-8, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22653583

ABSTRACT

Killer cell immunoglobulin-like receptors (KIRs) are involved in the pathogenesis of a variety of diseases. However, whether KIR polymorphism is associated with susceptibility to pulmonary tuberculosis was unknown. We examined a possible association of KIR polymorphism with susceptibility to pulmonary tuberculosis in Chinese Han. We analyzed 15 KIR genes in 109 pulmonary tuberculosis patients and 110 healthy controls using sequence-specific primer PCR analysis of genomic DNA. We found that the frequencies of KIR2DS1, 2DS3 and 3DS1 were significantly higher in patients than in the control group. In addition, the number of subjects carrying more than two activating KIR genes in the patient group was significantly higher than in the control group. The gene cluster containing KIR3DS1-2DL5-2DS1-2DS5 was also significantly more frequent in the patient group. In conclusion, KIR genes 2DS1, 2DS3 and 3DS1 appear to be associated with resistance to pulmonary tuberculosis in the Chinese Han population. KIR genes apparently have a role in resistance to pulmonary tuberculosis.


Subject(s)
Receptors, KIR/genetics , Tuberculosis, Pulmonary/genetics , Adult , Aged , Asian People , Female , Gene Frequency/genetics , Genetic Predisposition to Disease/genetics , Humans , Male , Middle Aged , Polymerase Chain Reaction , Receptors, KIR3DS1/genetics , Young Adult
20.
Opt Lett ; 37(11): 1850-2, 2012 Jun 01.
Article in English | MEDLINE | ID: mdl-22660050

ABSTRACT

We demonstrated a 1.91 µm pumped, injection-seeded Q-switched Ho:YAG laser operating at room temperature. By inserting two Fabry-Perot etalons into the laser cavity, single-frequency Tm, Ho:YAG seed lasing was achieved at a wavelength of 2090.9 nm, with a typical output power of 60 mW. Single-frequency, nearly transform-limited Q-switched operation of the Ho:YAG laser was achieved by injection seeding. The output energy of the single-frequency Q-switched pulse is 7.6 mJ, with a pulse width of 132 ns and a repetition rate of 100 Hz. We measured the pulse spectrum, half-width of which was 3.5 MHz, by a heterodyne technique.


Subject(s)
Lasers, Solid-State , Temperature , Injections
SELECTION OF CITATIONS
SEARCH DETAIL
...